Activated platelets may trigger alternative pathway activation (36–38), and the proteases of the coagulation and fibrinolysis cascades (both activated during COVID-19 but not or only poorly influenced by C1INH) are capable of cross-activating the CS at the level of C3 or C5 (39, 40). This evidence concerns the gene C3 and COVID-19.